Illumina INC:1107104 [18-045798]

Ended Purchase Order Awarded Last action

Contract number
75N91018P00545
Awardee
Awarding agency
Obligated
$12,875

Award facts

Contract value 100% obligated
$12,875.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
Bethesda, MD 20892, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00001 $0
Original award $12,875

About this award

The National Cancer Institute awarded a purchase order to Illumina, Inc. for $12,875.00 on July 25, 2018, with an ultimate completion date of July 31, 2019. No set-aside was used. Work is performed at Bethesda, Maryland. The order is priced on a firm fixed price basis and procures sequencing instruments, reagents, consumables, or bioinformatics software aligned with Illumina's product portfolio in support of cancer research operations.

Quick answers

Who was awarded contract 75N91018P00545?

75N91018P00545 was awarded to Illumina, Inc. by National Cancer Institute (National Institutes of Health) on July 25, 2018.

How much is contract 75N91018P00545 worth?

The government has obligated $12,875 on 75N91018P00545.

Was contract 75N91018P00545 competed?

The extent of competition for 75N91018P00545 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award